ADVLX
Price
$18.43
Change
+$0.01 (+0.05%)
Updated
Sep 12 closing price
Net Assets
37.76M
GGDPX
Price
$16.61
Change
-$0.04 (-0.24%)
Updated
Sep 12 closing price
Net Assets
5.57B
Interact to see
Advertisement

ADVLX vs GGDPX

Header iconADVLX vs GGDPX Comparison
Open Charts ADVLX vs GGDPXBanner chart's image
Vaughan Nelson International Cl I
Price$18.43
Change+$0.01 (+0.05%)
VolumeN/A
Net Assets37.76M
Goldman Sachs Intl Sm Cp Insghts P
Price$16.61
Change-$0.04 (-0.24%)
VolumeN/A
Net Assets5.57B
ADVLX vs GGDPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ADVLX vs. GGDPX commentary
Sep 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADVLX is a Buy and GGDPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GGDPX has more cash in the bank: 5.58B vs. ADVLX (37.8M). GGDPX pays higher dividends than ADVLX: GGDPX (3.62) vs ADVLX (1.19). ADVLX was incepted earlier than GGDPX: ADVLX (12 years) vs GGDPX (7 years). ADVLX (2.11) is less costly to investors than GGDPX (0.90). ADVLX is a more actively managed with annual turnover of: 205.00 vs. GGDPX (165.00). GGDPX has a lower initial minimum investment than ADVLX: GGDPX (0) vs ADVLX (100000). ADVLX annual gain was more profitable for investors over the last year : 43.84 vs. GGDPX (29.44). GGDPX return over 5 years is better than : 72.72 vs. ADVLX (46.93).
ADVLXGGDPXADVLX / GGDPX
Total Expense Ratio0.910.85107%
Annual Report Gross Expense Ratio2.110.90234%
Fund Existence12 years7 years-
Gain YTD38.60035.476109%
Front LoadN/AN/A-
Min. Initial Investment1000000-
Min. Initial Investment IRAN/AN/A-
Net Assets37.8M5.58B1%
Annual Yield % from dividends1.193.6233%
Returns for 1 year43.8429.44149%
Returns for 3 years54.5274.0274%
Returns for 5 years46.9372.7265%
Returns for 10 years102.66N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KUKE1.580.08
+5.33%
Kuke Music Holding Limited
ABT133.731.08
+0.81%
Abbott Laboratories
GLUE4.81-0.08
-1.64%
Monte Rosa Therapeutics
ASTH29.83-0.55
-1.81%
Astrana Health
ESAB110.28-2.80
-2.48%
ESAB Corp